 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, August 1, 2000, 20(15):5587-5593
Complete and Long-Term Rescue of Lesioned Adult Motoneurons by Lentiviral-Mediated Expression of Glial Cell Line-Derived Neurotrophic Factor in the Facial Nucleus
Andreas F. Hottinger, Mimoun Azzouz, Nicole Déglon, Patrick Aebischer, and Anne D. Zurn Division of Surgical Research and Gene Therapy Center, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
To date, delivery of neurotrophic factors has only allowed to transiently protect axotomized facial motoneurons against cell death. In the present report, long-term protection of these neurons was evaluated by continuously expressing the neurotrophic factor glial cell line-derived neurotrophic factor (GDNF) within the facial nucleus using a lentiviral vector system. The viral vector was injected unilaterally into the facial nucleus of 4-month-old Balb/C mice. In contrast to axotomy in other adult rodents, facial nerve lesion in these animals leads to a progressive and sustained loss and/or atrophy of >50% of the motoneurons. This model thus represents an attractive model to evaluate potential protective effects of neurotrophic factors for adult-onset motoneuron diseases, such as amyotrophic lateral sclerosis. One month after unilateral lentiviral vector injection, the facial nerve was sectioned, and the animals were killed 3 months later. Viral delivery of the GDNF gene led to long-term expression and extensive diffusion of GDNF within the brainstem. In addition, axotomized motoneurons were completely protected against cell death, because 95% of the motoneurons were present as demonstrated by both Nissl staining and choline acetyltransferase immunoreactivity. Furthermore, GDNF prevented lesion-induced neuronal atrophy and maintained proximal motoneuron axons, despite the absence of target cell reinnervation. This is the first evidence that viral-mediated delivery of GDNF close to the motoneuron cell bodies of the facial nucleus of adult mice can lead to complete and long-term protection against lesion-induced cell death.
Key words: axotomy; facial nerve; GDNF; gene expression; gene therapy; gene transfer; lentiviral vector; motoneuron; neuroprotection; neurotrophic factor; Balb/C mice
Copyright © 2000 Society for Neuroscience 0270-6474/00/20155587-07$05.00/0
This article has been cited by other articles:
S. Alves, E. Regulier, I. Nascimento-Ferreira, R. Hassig, N. Dufour, A. Koeppen, A. L. Carvalho, S. Simoes, M. C. P. de Lima, E. Brouillet, et al.
Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease
Hum. Mol. Genet., July 15, 2008; 17(14): 2071 - 2083.
[Abstract] [Full Text] [PDF]
A. Benchoua, Y. Trioulier, E. Diguet, C. Malgorn, M.-C. Gaillard, N. Dufour, J.-M. Elalouf, S. Krajewski, P. Hantraye, N. Deglon, et al.
Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II
Hum. Mol. Genet., May 15, 2008; 17(10): 1446 - 1456.
[Abstract] [Full Text] [PDF]
C. Escartin, E. Brouillet, P. Gubellini, Y. Trioulier, C. Jacquard, C. Smadja, G. W. Knott, L. K.-L. Goff, N. Deglon, P. Hantraye, et al.
Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo.
J. Neurosci., May 31, 2006; 26(22): 5978 - 5989.
[Abstract] [Full Text] [PDF]
R. Pardo, E. Colin, E. Regulier, P. Aebischer, N. Deglon, S. Humbert, and F. Saudou
Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421
J. Neurosci., February 1, 2006; 26(5): 1635 - 1645.
[Abstract] [Full Text] [PDF]
C. Akazawa, H. Tsuzuki, Y. Nakamura, Y. Sasaki, K. Ohsaki, S. Nakamura, Y. Arakawa, and S. Kohsaka
The Upregulated Expression of Sonic Hedgehog in Motor Neurons after Rat Facial Nerve Axotomy
J. Neurosci., September 8, 2004; 24(36): 7923 - 7930.
[Abstract] [Full Text] [PDF]
W. Sun, T. W. Gould, S. Vinsant, D. Prevette, and R. W. Oppenheim
Neuromuscular Development after the Prevention of Naturally Occurring Neuronal Death by Bax Deletion
J. Neurosci., August 13, 2003; 23(19): 7298 - 7310.
[Abstract] [Full Text] [PDF]
K. A. Huey, F. Haddad, A. X. Qin, and K. M. Baldwin
Transcriptional regulation of the type I myosin heavy chain gene in denervated rat soleus
Am J Physiol Cell Physiol, March 1, 2003; 284(3): C738 - C748.
[Abstract] [Full Text] [PDF]
M. Azzouz, E. Martin-Rendon, R. D. Barber, K. A. Mitrophanous, E. E. Carter, J. B. Rohll, S. M. Kingsman, A. J. Kingsman, and N. D. Mazarakis
Multicistronic Lentiviral Vector-Mediated Striatal Gene Transfer of Aromatic L-Amino Acid Decarboxylase, Tyrosine Hydroxylase, and GTP Cyclohydrolase I Induces Sustained Transgene Expression, Dopamine Production, and Functional Improvement in a Rat Model of Parkinson's Disease.
J. Neurosci., December 1, 2002; 22(23): 10302 - 10312.
[Abstract] [Full Text] [PDF]
C. Lo Bianco, J-L. Ridet, B. L. Schneider, N. Deglon, and P. Aebischer
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
PNAS, August 6, 2002; 99(16): 10813 - 10818.
[Abstract] [Full Text] [PDF]
L. P. de Almeida, C. A. Ross, D. Zala, P. Aebischer, and N. Deglon
Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length
J. Neurosci., May 1, 2002; 22(9): 3473 - 3483.
[Abstract] [Full Text] [PDF]
J. H. Kordower, M. E. Emborg, J. Bloch, S. Y. Ma, Y. Chu, L. Leventhal, J. McBride, E.-Y. Chen, S. Palfi, B. Z. Roitberg, et al.
Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease
Science, October 27, 2000; 290(5492): 767 - 773.
[Abstract] [Full Text]
|
|
|
|
 |
|